Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials.

Identifieur interne : 000F20 ( Main/Exploration ); précédent : 000F19; suivant : 000F21

Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials.

Auteurs : Fatemeh Oroojalian [Iran] ; Ali Haghbin [Iran] ; Behzad Baradaran [Iran] ; Nima Hemmat [Iran] ; Mohammad-Ali Shahbazi [Iran] ; Hossein Bannazadeh Baghi [Iran] ; Ahad Mokhtarzadeh [Iran] ; Michael R. Hamblin [Afrique du Sud]

Source :

RBID : pubmed:32991900

Descripteurs français

English descriptors

Abstract

The emergence of the global pandemic caused by the novel SARS-CoV-2 virus has motivated scientists to find a definitive treatment or a vaccine against it in the shortest possible time. Current efforts towards this goal remain fruitless without a full understanding of the behavior of the virus and its adaptor proteins. This review provides an overview of the biological properties, functional mechanisms, and molecular components of SARS-CoV-2, along with investigational therapeutic and preventive approaches for this virus. Since the proteolytic cleavage of the S protein is critical for virus penetration into cells, a set of drugs, such as chloroquine, hydroxychloroquine, camostat mesylate have been tested in clinical trials to suppress this event. In addition to angiotensin-converting enzyme 2, the role of CD147 in the viral entrance has also been proposed. Mepolizumab has shown to be effective in blocking the virus's cellular entrance. Antiviral drugs, such as remdesivir, ritonavir, oseltamivir, darunavir, lopinavir, zanamivir, peramivir, and oseltamivir, have also been tested as treatments for COVID-19. Regarding preventive vaccines, the whole virus, vectors, nucleic acids, and structural subunits have been suggested for vaccine development. Mesenchymal stem cells and natural killer cells could also be used against SARS-CoV-2. All the above-mentioned strategies, as well as the role of nanomedicine for the diagnosis and treatment of SARS-CoV-2 infection, have been discussed in this review.

DOI: 10.1016/j.ijbiomac.2020.09.204
PubMed: 32991900
PubMed Central: PMC7521454


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials.</title>
<author>
<name sortKey="Oroojalian, Fatemeh" sort="Oroojalian, Fatemeh" uniqKey="Oroojalian F" first="Fatemeh" last="Oroojalian">Fatemeh Oroojalian</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Advanced Sciences and Technologies in Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Advanced Sciences and Technologies in Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd</wicri:regionArea>
<wicri:noRegion>Bojnurd</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Haghbin, Ali" sort="Haghbin, Ali" uniqKey="Haghbin A" first="Ali" last="Haghbin">Ali Haghbin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Pediatrics, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd</wicri:regionArea>
<wicri:noRegion>Bojnurd</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Baradaran, Behzad" sort="Baradaran, Behzad" uniqKey="Baradaran B" first="Behzad" last="Baradaran">Behzad Baradaran</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz</wicri:regionArea>
<wicri:noRegion>Tabriz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hemmat, Nima" sort="Hemmat, Nima" uniqKey="Hemmat N" first="Nima" last="Hemmat">Nima Hemmat</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz</wicri:regionArea>
<wicri:noRegion>Tabriz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shahbazi, Mohammad Ali" sort="Shahbazi, Mohammad Ali" uniqKey="Shahbazi M" first="Mohammad-Ali" last="Shahbazi">Mohammad-Ali Shahbazi</name>
<affiliation wicri:level="4">
<nlm:affiliation>Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Baghi, Hossein Bannazadeh" sort="Baghi, Hossein Bannazadeh" uniqKey="Baghi H" first="Hossein Bannazadeh" last="Baghi">Hossein Bannazadeh Baghi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz</wicri:regionArea>
<wicri:noRegion>Tabriz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mokhtarzadeh, Ahad" sort="Mokhtarzadeh, Ahad" uniqKey="Mokhtarzadeh A" first="Ahad" last="Mokhtarzadeh">Ahad Mokhtarzadeh</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: mokhtarzadehah@tbzmed.ac.ir.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz</wicri:regionArea>
<wicri:noRegion>Tabriz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hamblin, Michael R" sort="Hamblin, Michael R" uniqKey="Hamblin M" first="Michael R" last="Hamblin">Michael R. Hamblin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA; Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein 2028, South Africa. Electronic address: hamblin@helix.mgh.harvard.edu.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA; Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein 2028</wicri:regionArea>
<wicri:noRegion>Doornfontein 2028</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32991900</idno>
<idno type="pmid">32991900</idno>
<idno type="doi">10.1016/j.ijbiomac.2020.09.204</idno>
<idno type="pmc">PMC7521454</idno>
<idno type="wicri:Area/Main/Corpus">000B29</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B29</idno>
<idno type="wicri:Area/Main/Curation">000B29</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000B29</idno>
<idno type="wicri:Area/Main/Exploration">000B29</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials.</title>
<author>
<name sortKey="Oroojalian, Fatemeh" sort="Oroojalian, Fatemeh" uniqKey="Oroojalian F" first="Fatemeh" last="Oroojalian">Fatemeh Oroojalian</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Advanced Sciences and Technologies in Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Advanced Sciences and Technologies in Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd</wicri:regionArea>
<wicri:noRegion>Bojnurd</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Haghbin, Ali" sort="Haghbin, Ali" uniqKey="Haghbin A" first="Ali" last="Haghbin">Ali Haghbin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Pediatrics, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd</wicri:regionArea>
<wicri:noRegion>Bojnurd</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Baradaran, Behzad" sort="Baradaran, Behzad" uniqKey="Baradaran B" first="Behzad" last="Baradaran">Behzad Baradaran</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz</wicri:regionArea>
<wicri:noRegion>Tabriz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hemmat, Nima" sort="Hemmat, Nima" uniqKey="Hemmat N" first="Nima" last="Hemmat">Nima Hemmat</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz</wicri:regionArea>
<wicri:noRegion>Tabriz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shahbazi, Mohammad Ali" sort="Shahbazi, Mohammad Ali" uniqKey="Shahbazi M" first="Mohammad-Ali" last="Shahbazi">Mohammad-Ali Shahbazi</name>
<affiliation wicri:level="4">
<nlm:affiliation>Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Baghi, Hossein Bannazadeh" sort="Baghi, Hossein Bannazadeh" uniqKey="Baghi H" first="Hossein Bannazadeh" last="Baghi">Hossein Bannazadeh Baghi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz</wicri:regionArea>
<wicri:noRegion>Tabriz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mokhtarzadeh, Ahad" sort="Mokhtarzadeh, Ahad" uniqKey="Mokhtarzadeh A" first="Ahad" last="Mokhtarzadeh">Ahad Mokhtarzadeh</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: mokhtarzadehah@tbzmed.ac.ir.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz</wicri:regionArea>
<wicri:noRegion>Tabriz</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hamblin, Michael R" sort="Hamblin, Michael R" uniqKey="Hamblin M" first="Michael R" last="Hamblin">Michael R. Hamblin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA; Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein 2028, South Africa. Electronic address: hamblin@helix.mgh.harvard.edu.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA; Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein 2028</wicri:regionArea>
<wicri:noRegion>Doornfontein 2028</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">International journal of biological macromolecules</title>
<idno type="eISSN">1879-0003</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral Agents (therapeutic use)</term>
<term>COVID-19 (drug therapy)</term>
<term>COVID-19 (immunology)</term>
<term>COVID-19 (therapy)</term>
<term>Clinical Trials as Topic (MeSH)</term>
<term>Humans (MeSH)</term>
<term>SARS-CoV-2 (drug effects)</term>
<term>SARS-CoV-2 (immunology)</term>
<term>SARS-CoV-2 (physiology)</term>
<term>Viral Vaccines (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antiviraux (usage thérapeutique)</term>
<term>Essais cliniques comme sujet (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Vaccins antiviraux (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>COVID-19</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Clinical Trials as Topic</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Essais cliniques comme sujet</term>
<term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The emergence of the global pandemic caused by the novel SARS-CoV-2 virus has motivated scientists to find a definitive treatment or a vaccine against it in the shortest possible time. Current efforts towards this goal remain fruitless without a full understanding of the behavior of the virus and its adaptor proteins. This review provides an overview of the biological properties, functional mechanisms, and molecular components of SARS-CoV-2, along with investigational therapeutic and preventive approaches for this virus. Since the proteolytic cleavage of the S protein is critical for virus penetration into cells, a set of drugs, such as chloroquine, hydroxychloroquine, camostat mesylate have been tested in clinical trials to suppress this event. In addition to angiotensin-converting enzyme 2, the role of CD147 in the viral entrance has also been proposed. Mepolizumab has shown to be effective in blocking the virus's cellular entrance. Antiviral drugs, such as remdesivir, ritonavir, oseltamivir, darunavir, lopinavir, zanamivir, peramivir, and oseltamivir, have also been tested as treatments for COVID-19. Regarding preventive vaccines, the whole virus, vectors, nucleic acids, and structural subunits have been suggested for vaccine development. Mesenchymal stem cells and natural killer cells could also be used against SARS-CoV-2. All the above-mentioned strategies, as well as the role of nanomedicine for the diagnosis and treatment of SARS-CoV-2 infection, have been discussed in this review.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32991900</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>12</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2021</Year>
<Month>05</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-0003</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>165</Volume>
<Issue>Pt A</Issue>
<PubDate>
<Year>2020</Year>
<Month>Dec</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>International journal of biological macromolecules</Title>
<ISOAbbreviation>Int J Biol Macromol</ISOAbbreviation>
</Journal>
<ArticleTitle>Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials.</ArticleTitle>
<Pagination>
<MedlinePgn>18-43</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0141-8130(20)34564-5</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijbiomac.2020.09.204</ELocationID>
<Abstract>
<AbstractText>The emergence of the global pandemic caused by the novel SARS-CoV-2 virus has motivated scientists to find a definitive treatment or a vaccine against it in the shortest possible time. Current efforts towards this goal remain fruitless without a full understanding of the behavior of the virus and its adaptor proteins. This review provides an overview of the biological properties, functional mechanisms, and molecular components of SARS-CoV-2, along with investigational therapeutic and preventive approaches for this virus. Since the proteolytic cleavage of the S protein is critical for virus penetration into cells, a set of drugs, such as chloroquine, hydroxychloroquine, camostat mesylate have been tested in clinical trials to suppress this event. In addition to angiotensin-converting enzyme 2, the role of CD147 in the viral entrance has also been proposed. Mepolizumab has shown to be effective in blocking the virus's cellular entrance. Antiviral drugs, such as remdesivir, ritonavir, oseltamivir, darunavir, lopinavir, zanamivir, peramivir, and oseltamivir, have also been tested as treatments for COVID-19. Regarding preventive vaccines, the whole virus, vectors, nucleic acids, and structural subunits have been suggested for vaccine development. Mesenchymal stem cells and natural killer cells could also be used against SARS-CoV-2. All the above-mentioned strategies, as well as the role of nanomedicine for the diagnosis and treatment of SARS-CoV-2 infection, have been discussed in this review.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Oroojalian</LastName>
<ForeName>Fatemeh</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Advanced Sciences and Technologies in Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haghbin</LastName>
<ForeName>Ali</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran; Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baradaran</LastName>
<ForeName>Behzad</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hemmat</LastName>
<ForeName>Nima</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shahbazi</LastName>
<ForeName>Mohammad-Ali</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baghi</LastName>
<ForeName>Hossein Bannazadeh</ForeName>
<Initials>HB</Initials>
<AffiliationInfo>
<Affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mokhtarzadeh</LastName>
<ForeName>Ahad</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: mokhtarzadehah@tbzmed.ac.ir.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hamblin</LastName>
<ForeName>Michael R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA; Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein 2028, South Africa. Electronic address: hamblin@helix.mgh.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AI050875</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 AI121700</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Int J Biol Macromol</MedlineTA>
<NlmUniqueID>7909578</NlmUniqueID>
<ISSNLinking>0141-8130</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Global pandemic</Keyword>
<Keyword MajorTopicYN="N">Investigational drugs</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">Vaccine development</Keyword>
<Keyword MajorTopicYN="N">Virus mechanism</Keyword>
</KeywordList>
<CoiStatement>Declaration of competing interest MRH declares the following potential conflicts of interest. Scientific Advisory Boards: Transdermal Cap Inc., Cleveland, OH; BeWell Global Inc., Wan Chai, Hong Kong; Hologenix Inc. Santa Monica, CA; LumiThera Inc., Poulsbo, WA; Vielight, Toronto, Canada; Bright Photomedicine, Sao Paulo, Brazil; Quantum Dynamics LLC, Cambridge, MA; Global Photon Inc., Bee Cave, TX; Medical Coherence, Boston MA; NeuroThera, Newark DE; JOOVV Inc., Minneapolis-St. Paul MN; AIRx Medical, Pleasanton CA; FIR Industries, Inc. Ramsey, NJ; UVLRx Therapeutics, Oldsmar, FL; Ultralux UV Inc., Lansing MI; Illumiheal & Petthera, Shoreline, WA; MB Lasertherapy, Houston, TX; ARRC LED, San Clemente, CA; Varuna Biomedical Corp. Incline Village, NV; Niraxx Light Therapeutics, Inc., Boston, MA. Consulting; Lexington Int, Boca Raton, FL; USHIO Corp, Japan; Merck KGaA, Darmstadt, Germany; Philips Electronics Nederland B.V. Eindhoven, Netherlands; Johnson & Johnson Inc., Philadelphia, PA; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany. Stockholdings: Global Photon Inc., Bee Cave, TX; Mitonix, Newark, DE.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>08</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>09</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>09</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>9</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>12</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>20</Hour>
<Minute>8</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32991900</ArticleId>
<ArticleId IdType="pii">S0141-8130(20)34564-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.ijbiomac.2020.09.204</ArticleId>
<ArticleId IdType="pmc">PMC7521454</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Annu Rev Virol. 2015 Nov;2(1):265-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26958916</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2003 Jun 21;326(7403):1358-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12816821</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14408-14413</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27911847</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2005 Sep;112(1-2):24-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16022898</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2020 Mar;579(7798):270-273</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32015507</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32075877</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2016 Dec 15;214(suppl 5):S497-S499</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27920180</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Nano. 2014 Jan 28;8(1):458-466</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24341611</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Differ. 2018 Jul;25(7):1209-1223</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29238069</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 Jul;87(14):8017-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23678171</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2020 Mar 9;16(3):e1008392</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32150576</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Saudi Pharm J. 2018 Jan;26(1):64-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29379334</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32187464</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Rev. 2015 Apr;28(2):465-522</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25810418</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Crit Care Med. 2018 May;19(5):505</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29727426</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3621-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26976597</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 Jul;87(14):7790-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23678167</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccines (Basel). 2019 May 28;7(2):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31141982</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Nano. 2009 May 26;3(5):1219-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19422193</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2013 Jun 6;368(23):2159-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23688302</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chem Asian J. 2019 Nov 18;14(22):3962-3968</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31389664</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2019 Jan 9;25(1):13-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30629914</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2020 Apr;8(4):420-422</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32085846</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Stem Cell Res Ther. 2014;9(4):319-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24588087</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2017 Mar 27;18(4):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28346367</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Jun;78(11):5612-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15140958</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intensive Care Med. 2020 May;46(5):854-887</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32222812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mil Med Res. 2020 Mar 13;7(1):11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32169119</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Med Sci. 2012;9(2):157-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22253563</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Jun;92(6):595-601</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32100877</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Biol Ther. 2015;15(11):1647-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26414077</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Discov. 2020 Feb 24;6:11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32133153</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 Nov;87(21):11950-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23986586</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2009 Aug 6;27(36):5001-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19523911</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stem Cells Transl Med. 2019 Oct;8(10):1092-1106</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31219247</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2004 Mar 12;303(5664):1666-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14752165</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2004 Dec;10(12):1062-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15606632</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2012 Nov 12;4(11):3044-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23202515</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2004 Oct;2(10):820-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15378046</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Oct;92(10):1735-1738</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32243608</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Asian Pac J Allergy Immunol. 2020 Mar;38(1):10-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32134278</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Pathol. 2004 Apr;121(4):507-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15080302</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Cent Sci. 2020 Mar 25;6(3):315-331</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32226821</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 2010 Sep;38(9):1845-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20581666</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Med. 2019 Jun 13;8(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31200579</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2006 Sep;3(9):e343</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16968120</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2005 Aug;43(8):3718-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16081901</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Adv Res. 2020 Mar 16;24:91-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32257431</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Jan;29(1):90-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28459413</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Nephrol Hypertens. 2011 Jan;20(1):62-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21099686</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Mar 21;395(10228):931-934</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32164834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Korean Med Sci. 2020 Feb 10;35(5):e61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32030925</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Microbiol. 2019 Jan 29;10:50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30761102</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Biol Macromol. 2018 Jul 15;114:1008-1017</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29621501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Virol. 2016 Sep 29;3(1):237-261</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27578435</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2018 Jun 7;36(24):3468-3476</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29739720</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharm Anal. 2020 Apr;10(2):102-108</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32282863</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>F1000Res. 2019 Sep 12;8:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31559009</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Jul 28;71(15):762-768</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32161940</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2015 Jun 02;7(6):2794-815</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26043381</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2005 May 2;23(24):3202-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15837221</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Infect Dis. 2015 Jul 10;1(7):317-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27622822</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2009 Mar;7(3):226-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19198616</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2015 Jan 1;211(1):80-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25030060</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2015 Jul 28;6:7712</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26218507</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2018 Oct 04;9:2224</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30337923</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Small. 2016 Mar 2;12(9):1133-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26551316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2012 Aug;122(8):2731-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22850883</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Microbes Infect. 2020 Dec;9(1):542-544</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32148172</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2013 Oct;100(1):246-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23994189</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anal Chem. 2017 May 16;89(10):5428-5435</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28394582</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cytotherapy. 2016 Nov;18(11):1435-1445</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27745603</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2018 Sep 26;9:2180</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30319635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 2014 Sep;44(3):765-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24791828</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14651994</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2017 Jan 04;7:39889</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28051154</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2012 Mar 16;287(12):8904-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22291007</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2019 Mar 5;93(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30567993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunity. 2016 Jun 21;44(6):1379-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27287409</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9804-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15210961</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2015 Apr 16;202:120-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25445340</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2005 Jan;107(1):93-101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15567038</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Apr 28;323(16):1582-1589</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32219428</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2012 Jun;4(6):1011-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22816037</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain Res. 2020 Feb 07;13:331-343</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32104055</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Rev Vaccines. 2016 Sep;15(9):1123-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26985862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17039-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15572443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Life Sci. 2020 Jun 1;250:117583</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32217117</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Korean Med Sci. 2020 Feb 17;35(6):e79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32056407</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Nanotechnol. 2020 Aug;15(8):622-624</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32747742</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2020 May;19(5):305-306</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32273591</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Rev Biochem Mol Biol. 2008 May-Jun;43(3):189-219</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18568847</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Feb;79(4):2079-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15681410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 Jun 28;6:28698</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27350308</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1095-1110</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28954547</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2014 Jan;88(2):913-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24198408</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16081529</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2020 Mar 17;94(7):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31996437</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Feb;81(4):1701-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17108030</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2014 Sep 29;15(10):17577-600</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25268624</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Control Release. 2019 Dec 28;316:116-137</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31669566</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2011 May;85(9):4122-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21325420</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S223-7, discussion S226</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16378050</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2014 Jan 23;15(2):1719-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24463293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2015 Jan;3(1):24-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25529339</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Negl Trop Dis. 2015 Sep 04;9(9):e0004007</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26340754</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging Dis. 2020 Mar 9;11(2):216-228</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32257537</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2020 Mar;19(3):149-150</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32127666</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>mBio. 2018 Mar 6;9(2):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29511076</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccines (Basel). 2020 Mar 29;8(2):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32235387</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Hypertens. 2012;2012:307315</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22121476</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circ Res. 2016 Apr 15;118(8):1313-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27081112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Microbiol. 2016 Mar;18(3):424-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26350435</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2017 Feb 9;376(6):584-594</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28177862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Genet. 2015;89:179-233</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25620012</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Microbiol. 2004 May;53(Pt 5):435-438</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15096554</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Chin Med Assoc. 2020 Jun;83(6):534-536</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32243270</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Traffic. 2016 Jun;17(6):569-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26875443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Insights. 2019 Jan 27;12:1178636118825081</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30728724</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2005 Oct 1;106(7):2366-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15860669</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2014 May 30;32(26):3169-3174</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24736006</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2015 Jun;89(11):6117-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25787284</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2018;14(11):1850-1869</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29985091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stem Cells Transl Med. 2015 Oct;4(10):1199-213</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26285659</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Microbiol. 2019 Aug 02;10:1781</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31428074</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Transl Med. 2016 Jul;4(14):261</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27563648</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26976607</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Apr;78(7):3572-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15016880</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biosci Rep. 2015 Nov 24;36(1):e00283</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26604323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Regul Homeost Agents. 2020 Jun 04;34(3):1241-1243</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32551464</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2015 Aug 1;195(3):875-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26116507</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2005 Dec;5(12):917-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16322745</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anat Rec (Hoboken). 2020 Jun;303(6):1584-1589</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30768865</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Respir Med Case Rep. 2020;31:101205</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32874905</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2018 Apr;17(4):261-279</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29326426</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Respir Res. 2018 Nov 9;19(1):218</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30413158</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viral Immunol. 2011 Oct;24(5):421-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21958371</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Pharm Des. 2015;21(42):6214-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26503143</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2020 May;177:104759</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32130973</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Allergy. 2020 Jul;75(7):1564-1581</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32396996</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2017 Jan;137:82-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27840203</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Microbiol. 2020 Apr;5(4):536-544</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32123347</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Transl Med. 2019 Sep 12;8(1):25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31512000</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2019 Jan 14;11(1):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30646565</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Sep 16;309(5742):1864-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16166518</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Analyt Chem. 2017 Dec;97:445-457</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32287543</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2006 Mar;87(Pt 3):641-650</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16476986</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2020 Mar 27;367(6485):1444-1448</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32132184</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Protoplasma. 2010 Aug;244(1-4):15-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20446005</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Saf. 2015 Jan;38(1):33-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25416320</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Korean Med Sci. 2020 Feb 24;35(7):e88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32080992</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Signal Transduct Target Ther. 2020 Dec 4;5(1):283</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33277466</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Indian J Med Res. 2020 Feb & Mar;151(2 & 3):184-189</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32362644</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci China Life Sci. 2020 Mar;63(3):457-460</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32009228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6641-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15096611</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2005 Apr 10;334(2):160-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15780866</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Nanomedicine. 2012;7:2173-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22619553</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Formos Med Assoc. 2020 Mar;119(3):670-673</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32139299</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biochem. 2019 Oct;120(10):17194-17207</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31104319</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Biol Sci. 2020 Mar 15;16(10):1678-1685</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32226285</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>One Health. 2020 Feb 24;9:100124</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32195311</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2009 Jul;175(1):303-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19497992</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Apr 23;279(17):17996-8007</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14754895</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Control Release. 2020 May 10;321:442-462</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32067996</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chem Biol Drug Des. 2009 Jan;73(1):53-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19152635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 Dec 18;8(12):e83303</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24367590</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2020 Feb 17;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32081428</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diseases. 2016 Jul 25;4(3):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28933406</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2015 Aug 19;7(301):301ra132</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26290414</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2017 Mar 14;35(12):1586-1589</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28237499</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antivir Ther. 2007;12(4 Pt B):651-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17944272</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2012 Nov;181(5):1681-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23083833</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>mBio. 2015 Sep 29;6(5):e01303-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26419878</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Biotechnol. 2007 Dec;18(6):546-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18063357</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Investig Drugs. 2020 Jan;29(1):49-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31778609</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Jun;92(6):693-697</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32167173</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Vaccin Immunother. 2017 Dec 2;13(12):2918-2930</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28846484</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Dev Res. 2020 Aug;81(5):537-540</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32129518</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2012 Apr;4(4):557-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22590686</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Lung Res. 2017 Mar;43(2):66-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28353351</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccines (Basel). 2014 Jul 29;2(3):624-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26344749</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2012 Jun;94(3):288-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22265858</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Nanomedicine. 2014 Apr 10;9:1833-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24748793</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2016 Nov 22;7:13473</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27874853</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2015 Nov 17;314(19):2034-2044</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26575060</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thorax. 2012 Jun;67(6):533-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22250097</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 2017 Dec;162(12):3567-3585</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28866775</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15214-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25288733</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32142651</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Neurol Scand. 2017 Feb;135(2):148-160</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27364959</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2004 Jun 15;103(12):4619-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15001472</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32105090</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Glob Health. 2018 Dec;6(12):e1386-e1396</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30342925</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2008 Apr;133(1):45-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17416434</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Apr;92(4):424-432</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31981224</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Exp Immunol. 2004 Apr;136(1):95-103</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15030519</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Discov Today. 2020 Mar;25(3):552-560</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31843577</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2018 Oct 24;8(1):15701</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30356097</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2004 Sep 15;173(6):4030-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15356152</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Sens. 2019 Sep 27;4(9):2554</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31483133</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2019 Jan 17;11(1):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30658390</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Microbiol. 2019 Dec 19;10:2881</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31921059</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2017 Jul 11;8(28):45626-45642</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28484089</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Microbiol. 2020 Feb 28;11:298</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32265848</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2006 Apr 12;24(16):3100-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16494977</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Trauma Acute Care Surg. 2018 Jan;84(1):183-191</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29019797</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Afrique du Sud</li>
<li>Iran</li>
</country>
<region>
<li>Uusimaa</li>
</region>
<settlement>
<li>Helsinki</li>
</settlement>
<orgName>
<li>Université d'Helsinki</li>
</orgName>
</list>
<tree>
<country name="Iran">
<noRegion>
<name sortKey="Oroojalian, Fatemeh" sort="Oroojalian, Fatemeh" uniqKey="Oroojalian F" first="Fatemeh" last="Oroojalian">Fatemeh Oroojalian</name>
</noRegion>
<name sortKey="Baghi, Hossein Bannazadeh" sort="Baghi, Hossein Bannazadeh" uniqKey="Baghi H" first="Hossein Bannazadeh" last="Baghi">Hossein Bannazadeh Baghi</name>
<name sortKey="Baradaran, Behzad" sort="Baradaran, Behzad" uniqKey="Baradaran B" first="Behzad" last="Baradaran">Behzad Baradaran</name>
<name sortKey="Haghbin, Ali" sort="Haghbin, Ali" uniqKey="Haghbin A" first="Ali" last="Haghbin">Ali Haghbin</name>
<name sortKey="Hemmat, Nima" sort="Hemmat, Nima" uniqKey="Hemmat N" first="Nima" last="Hemmat">Nima Hemmat</name>
<name sortKey="Mokhtarzadeh, Ahad" sort="Mokhtarzadeh, Ahad" uniqKey="Mokhtarzadeh A" first="Ahad" last="Mokhtarzadeh">Ahad Mokhtarzadeh</name>
<name sortKey="Shahbazi, Mohammad Ali" sort="Shahbazi, Mohammad Ali" uniqKey="Shahbazi M" first="Mohammad-Ali" last="Shahbazi">Mohammad-Ali Shahbazi</name>
</country>
<country name="Afrique du Sud">
<noRegion>
<name sortKey="Hamblin, Michael R" sort="Hamblin, Michael R" uniqKey="Hamblin M" first="Michael R" last="Hamblin">Michael R. Hamblin</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F20 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F20 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32991900
   |texte=   Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32991900" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021